The Effect of Age, Parity and Body Mass Index on the Efficacy, Safety, Placement and User Satisfaction Associated With Two Low-Dose Levonorgestrel Intrauterine Contraceptive Systems: Subgroup Analyses of Data From a Phase III Trial

• Kristina Gemzell-Danielsson ,

  * E-mail: Kristina.Gemzell@ki.se

  Affiliation Department of Women’s and Children’s Health, Division of Obstetrics and Gynecology, Karolinska Institutet and Karolinska University Hospital, Stockholm, SE-171 76, Sweden

  ⨯
• Dan Apter,

  Affiliation Sexual Health Clinic (Family Federation of Finland), Väestöliitto, Helsinki, 00101, Finland

  ⨯
• Brian Hauck,

  Affiliation Department of Obstetrics and Gynecology, Foothills Hospital, University of Calgary, Calgary, Alberta, T2N 4J8, Canada

  ⨯
• Thomas Schmelter,

  Affiliation Bayer Pharma AG, Müllerstrasse 178, Berlin, 13353, Germany

  ⨯
• Sarah Rybowski,

  Affiliation Bayer HealthCare Pharmaceuticals, Whippany, New Jersey, United States of America

  ⨯
• Kimberly Rosen,

  Affiliation Bayer HealthCare Pharmaceuticals, Whippany, New Jersey, United States of America

  ⨯
• Anita Nelson

  Affiliation Los Angeles Biomedical Research Institute, Harbor-UCLA, 1000 West Carson Street Torrance, California, 90405, United States of America

  ⨯